Abstract:BACKGROUND & OBJECTIVE:Blocking tumor angiogenesis is a promising tumoricidal approach. Herpes simplex virus-thymidine kinase (HSV-tk) suicide gene could effectively damage neoplastic vascular endothelial cells. However, the killing effect of currently used HSV-tk system is non-specific due to employing cytomegalovirus (CMV) as its promoter. Kinase domain insert containing receptor (KDR), a kind of vascular endothelial growth factor receptor, is highly expressed on tumor vascular endothelial cells, but lowly expressed on normal tissues. This study was to construct a recombinant adenovirus containing KDR promoter-mediated HSV-tk suicide gene, and analyze its specific expression on vascular endothelial cells.METHODS:KDR-tk fragment was subcloned into corresponding restriction sites of vector with directional cloning method using pAdeasy system to construct recombinant adenoviral plasmid containing KDR promoter-controlled HSV-tk gene (AdKDR-tk). After packaged and amplified in 293 cells, the virus was used to infect KDR-expressed human umbilical venous endothelial cells (HUVECs) and KDR-unexpressed liver cancer cell line HepG2. After administration of ganciclovir (GCV), proliferation of gene-transfected HUVECs and HepG2 cells was evaluated by MTT assay.RESULTS:According to the results of restriction digestion, reverse transcription-polymerase chain reaction (RT-PCR) and PCR, the length, position and orientation of inserted genes were correct. The titer of the recombinant adenovirus was 1 x 10 (10) pfu/ml. Under infection index of 100, with the concentration of GCV increased from 0 to 50 microg/ml, the survival rates of AdKDR-tk-transfected HUVECs and HepG2 cells decreased from 100% to (28.94+/-5.67)% and (75.45+/-2.91)%, respectively (P<0.01).CONCLUSION:Adenovirus-mediated transfection of KDR promoter-HSV-tk gene could direct endothelial specific gene expression.

Adenovirus Vector Mediated HSV-tk Gene Killing Action on Lewis Lung Cancer Cells

Construction of Recombinant Adenovirus Ad-CMV-TK and Its Inhibitory Effect on Lewis Cells

Killing effect of mutant herpes simplex virus type 1 thymidine kinase on rat C6 glioma cells

[Experimental Study on Human Pulmonary Adenocarcinoma Cell A549 Transfected with HSV₁-TK Gene in Vitro and in Vivo].

Study of Adenoviral-Mediated Gene Therapy for Bladder Cancer Cell

Killing Action of the Adenovirus Vector Carrying HSV-TK on Synovial Cells of Pigmented Villonodular Synovitis

Antitumor Effect of HSV-TK Gene with Adenovirus Mediation on Alimentary Carcinoma

Adenovirus-Mediated Gene Transfer of Herpes Simplex Virus Thymidine Ki-nase under the Control of KDR Promoter Confers the Sensitivity to Ganciclov-ir in Human Vascular Endothelial Cells

Potent Anti-Tumor Activity of Telomerase-Dependent and HSV-TK Armed Oncolytic Adenovirus for Non-Small Cell Lung Cancer in Vitro and in Vivo

Construction of Recombinant Adenovirus Containing TK Gene and Its Effect Against Human Liver Cancer Cells

Study of Adenovirus-Mediated HSV-tk Gene Therapy for Bladder Cancer Cell Line

[The Adenovirus-Mediated HSV-TK/GCV Suicide Gene System in the Treatment of Tongue Carcinoma Cell Line].

Influence of TK adenovirus vector regulated by hypoxia and radiation on the growth and apoptosis of breast cancer cells

In Vivo Antitumor Activity of HSV-tk/CD Combinative Gene Toward Human Cholangiocarcinoma Cells(QBC939)

Therapeutic Mechanism of Adenovirus Mediated HSV-TK/GCV for Oral Squamous Carcinoma Cells in Vitro

Adenovirus-Mediated Hsv-Tk Gene Therapy Using Htert Promoter in Cne Cells in Vitro

[Construction and Identification of Recombinant Vectors Carrying Herpes Simplex Virus Thymidine Kinase Genes Expressed in Vascular Endothelial Cells].

[Adenovirus Mediated Double Suicide Gene under Controlling by KDR Promoter Selectively Kills Vascular Endothelial Cells and Colorectal Tumor Cells].

Co-expression of Herpes Simplex Virus Thymidine Kinase and Escherichia Coli Nitroreductase by an Htert-Driven Adenovirus Vector in Breast Cancer Cells Results in Additive Anti-Tumor Effects.

Killing Effect of TNF-mediated by Conditionally Replicating Adenovirus on Esophageal Cancer and Lung Cancer Cell Lines.

Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy for experimental prostate cancer